中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [29]
海洋研究所 [4]
西北高原生物研究所 [3]
上海营养与健康研究所 [2]
沈阳应用生态研究所 [2]
合肥物质科学研究院 [2]
更多
采集方式
OAI收割 [49]
iSwitch采集 [2]
内容类型
期刊论文 [47]
会议论文 [2]
学位论文 [2]
发表日期
2025 [1]
2022 [2]
2020 [1]
2019 [2]
2018 [5]
2017 [4]
更多
学科主题
Cardiovasc... [2]
Oncology [1]
地球科学::海洋科学... [1]
筛选
浏览/检索结果:
共51条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma
期刊论文
OAI收割
CANCER CELL INTERNATIONAL, 2025, 卷号: 25, 期号: 1, 页码: 12
作者:
Shi, Wenhao
;
Tang, Haotian
;
Tong, Linjiang
;
Song, Peiran
;
Huang, Yuqing
  |  
收藏
  |  
Multiple-dose up-titration study to evaluate the pharmacokinetics, safety and antitumor activity of apatinib in advanced gastric adenocarcinoma
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12, 页码: 10
作者:
Wang, Yonggang
;
Wang, Chang
;
Zhang, Yanqiao
;
Hao, Jiqing
;
Yang, Nong
  |  
收藏
  |  
Design and semisynthesis of oleanolic acid derivatives as VEGF in- hibitors: Inhibition of VEGF-induced proliferation, angiogenesis, and VEGFR2 activation in HUVECs
期刊论文
OAI收割
CHINESE JOURNAL OF NATURAL MEDICINES, 2022, 卷号: 20, 期号: 3, 页码: 229-240
作者:
Meng Ning
;
Xie Hong-Xu
;
Hou Jia-Rong
;
Chen Yon-Bin
;
Wu Meng-Jun
  |  
收藏
  |  
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2020, 卷号: 10
作者:
Jiang, Zongru
;
Wang, Li
;
Liu, Xuesong
;
Chen, Cheng
;
Wang, Beilei
  |  
收藏
  |  
Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation
期刊论文
OAI收割
CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 卷号: 93, 期号: 5, 页码: 934-948
作者:
Wang, Yu
;
Peng, Cheng
;
Wang, Guimin
;
Xu, Zhijian
;
Luo, Yongfeng
  |  
收藏
  |  
TAF1 plays a critical role in AML1-ETO driven leukemogenesis
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2019, 卷号: 10, 期号: -, 页码: 4925
作者:
Xu, Ye
;
Man, Na
;
Karl, Daniel
;
Martinez, Concepcion
;
Liu, Fan
  |  
收藏
  |  
Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-l-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 154, 页码: 9-28
作者:
Wei, Manman
;
Peng, Xia
;
Xing, Li
;
Dai, Yang
;
Huang, Ruimin
  |  
收藏
  |  
PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis
期刊论文
OAI收割
BIOCHEMICAL PHARMACOLOGY, 2018, 卷号: 150, 页码: 131-140
作者:
Fang, Xiaona
;
Xie, Hua
;
Luo, Min
;
Chen, Zhen
;
Wang, Fang
  |  
收藏
  |  
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor
期刊论文
OAI收割
CANCER SCIENCE, 2018, 卷号: 109, 期号: 4, 页码: 1207-1219
作者:
Xie, Chengying
;
Wan, Xiaozhe
;
Quan, Haitian
;
Zheng, Mingyue
;
Fu, Li
  |  
收藏
  |  
Ph-triggered peptide self-assembly for targeting imaging and therapy toward angiogenesis with enhanced signals
期刊论文
iSwitch采集
Acs applied materials & interfaces, 2018, 卷号: 10, 期号: 9, 页码: 7871-7881
作者:
Qian, Yixia
;
Wang, Weizhi
;
Wang, Zihua
;
Jia, Xiangqian
;
Han, Qiuju
收藏
  |